皮膚腺 (JP Patent Analysis Report)
The Technical Field "皮膚腺" had 200 patent application filings in the most recent period (2023-01-01 to 2023-03-31). This is a significantly decreased of -677 filings (-77.2%) over 877 they had in the same period of the previous year (2022-01-01 to 2022-03-31). This report also includes technical terms related to " 皮せん ", " 皮腺 ", " 皮膚せん " in the search set.
The highest number of filings in 2019 with 4,807 cases, and their lowest number in 2022 with 3,441 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 21,660 cases in total) is 3,610, and the median is 4,038. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 3,610 patents |
| Std Dev | 1,432 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 3,441 cases | -13.65 % |
| 2021 year | 3,985 cases | -2.57 % |
| 2020 year | 4,090 cases | -14.92 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 皮膚腺 for the period of the last 10 years (2014-01-01 to 2024-11-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 皮膚腺, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
皮膚腺, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 皮膚腺 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 39,689 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
皮膚腺
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 皮膚腺 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 105 cases, followed by ロレアル with 50 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 105 cases |
| ロレアル | 50 cases |
| 株式会社資生堂 | 39 cases |
| コーニンクレッカフィリップスエヌヴェ | 31 cases |
| ポーラ化成工業株式会社 | 26 cases |
| ザプロクターアンドギャンブルカンパニー | 20 cases |
| ライオン株式会社 | 19 cases |
| 株式会社コーセー | 18 cases |
| 株式会社ノエビア | 6 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 716 cases, followed by ロレアル with 641 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 716 cases |
| ロレアル | 641 cases |
| コーニンクレッカフィリップスエヌヴェ | 458 cases |
| ザプロクターアンドギャンブルカンパニー | 265 cases |
| 株式会社資生堂 | 250 cases |
| ポーラ化成工業株式会社 | 248 cases |
| 株式会社コーセー | 163 cases |
| ライオン株式会社 | 97 cases |
| 株式会社ノエビア | 84 cases |
| ユニリーバー・ナームローゼ・ベンノートシヤープ | 57 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 皮膚腺 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 105 cases, followed by ロレアル with 50 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 105 cases |
| ロレアル | 50 cases |
| 株式会社資生堂 | 39 cases |
| コーニンクレッカフィリップスエヌヴェ | 31 cases |
| ポーラ化成工業株式会社 | 26 cases |
| ザプロクターアンドギャンブルカンパニー | 20 cases |
| ライオン株式会社 | 19 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 716 cases, followed by ロレアル with 641 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 716 cases |
| ロレアル | 641 cases |
| コーニンクレッカフィリップスエヌヴェ | 458 cases |
| ザプロクターアンドギャンブルカンパニー | 265 cases |
| 株式会社資生堂 | 250 cases |
| ポーラ化成工業株式会社 | 248 cases |
| ライオン株式会社 | 97 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 皮膚腺’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 皮膚腺’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ロレアル
皮膚腺 filed 641 joint applications with ロレアル for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 307 cases in total) is 51.2, and the median is 60.5. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 111 cases, and their lowest number in 2022 with 45 cases.
| Index | Value |
|---|---|
| Average | 51.2 patents |
| Std Dev | 22.0 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 45 cases | -27.42 % |
| 2021 year | 62 cases | +5.08 % |
| 2020 year | 59 cases | -11.94 % |
Trends in filing of joint patent applications with 花王株式会社
皮膚腺 filed 716 joint applications with 花王株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 421 cases in total) is 70.2, and the median is 75.0. The coefficient of variation (standard deviation/mean) is 0.27, and there have been small fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2021 with 90 cases, and their lowest number in 2014 with 59 cases.
| Index | Value |
|---|---|
| Average | 70.2 patents |
| Std Dev | 19.2 |
| COV | 0.27 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 74 cases | -17.78 % |
| 2021 year | 90 cases | +15.38 % |
| 2020 year | 78 cases | +5.41 % |
Trends in filing of joint patent applications with 株式会社資生堂
皮膚腺 filed 250 joint applications with 株式会社資生堂 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 167 cases in total) is 27.8, and the median is 28.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2019 with 50 cases, and their lowest number in 2015 with 15 cases.
| Index | Value |
|---|---|
| Average | 27.8 patents |
| Std Dev | 12.3 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 28 cases | +33.3 % |
| 2021 year | 21 cases | -32.3 % |
| 2020 year | 31 cases | -38.0 % |
Trends in filing of joint patent applications with ポーラ化成工業株式会社
皮膚腺 filed 248 joint applications with ポーラ化成工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 139 cases in total) is 23.2, and the median is 25.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2020 with 35 cases, and their lowest number in 2017 with 17 cases.
| Index | Value |
|---|---|
| Average | 23.2 patents |
| Std Dev | 8.9 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 18 cases | -30.8 % |
| 2021 year | 26 cases | -25.71 % |
| 2020 year | 35 cases | +45.8 % |
Trends in filing of joint patent applications with ザプロクターアンドギャンブルカンパニー
皮膚腺 filed 265 joint applications with ザプロクターアンドギャンブルカンパニー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 105 cases in total) is 17.5, and the median is 18.0. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 53 cases, and their lowest number in 2021 with 15 cases.
| Index | Value |
|---|---|
| Average | 17.5 patents |
| Std Dev | 9.6 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 19 cases | +26.67 % |
| 2021 year | 15 cases | -21.05 % |
| 2020 year | 19 cases | +11.76 % |
Information on important patents (JP)
The following shows JP patents held by 皮膚腺 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 皮膚腺’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 皮膚腺 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許6189374 "糖尿病療法" (Invalidation Trial day 2024-01-31) , next is 特許7185426 "Ｓ１Ｐ受容体モジュレーターの投与計画" (Invalidation Trial day 2023-07-10) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許6189374 | 糖尿病療法 | 2024-01-31 |
| 2 | 特許7185426 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-07-10 |
| 3 | 特許5474043 | （＋）−２−［１−（３−エトキシ−４−メトキシフェニル）−２−メチルスルホニルエチル］−４−アセチルアミノイソインドリン−１，３−ジオンを含む固形物形態、その組成物およびその使用 | 2023-05-31 |
| 4 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 5 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 6 | 特許4414623 | 病原微生物および抗微生物剤の検出法、抗微生物剤の薬効評価法ならびに抗微生物剤 | 2023-01-11 |
| 7 | 特許6914336 | 進行したＨＥＲ２発現がんの治療 | 2022-11-15 |
| 8 | 特許6966812 | 皮膚刺激ブラシ | 2022-05-02 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6189374 "糖尿病療法" (1 times) , and the next most invalidation trial patent is 特許6966812 "皮膚刺激ブラシ" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6189374 | 糖尿病療法 | 1 times |
| 2 | 特許6966812 | 皮膚刺激ブラシ | 1 times |
| 3 | 特許6896700 | ワクチン組成物 | 1 times |
| 4 | 特許6258428 | 肺癌治療剤 | 1 times |
| 5 | 特許6914336 | 進行したＨＥＲ２発現がんの治療 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 52 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7459360 "水中油型乳化組成物" (Opposition day 2024-09-30) , next is 特許7426362 "化粧動作支援システム" (Opposition day 2024-08-01) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7459360 | 水中油型乳化組成物 | 2024-09-30 |
| 2 | 特許7426362 | 化粧動作支援システム | 2024-08-01 |
| 3 | 特許7425092 | 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 | 2024-07-29 |
| 4 | 特許7389638 | 中華風味油の製造方法 | 2024-05-30 |
| 5 | 特許7382615 | 外用剤 | 2024-05-15 |
| 6 | 特許7376250 | 皮膚外用組成物 | 2024-04-20 |
| 7 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 8 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 9 | 特許7290765 | 油中水型乳化組成物 | 2023-12-08 |
| 10 | 特許7282155 | 頭皮用外用組成物 | 2023-11-24 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 313 patents Protest from third parties. The average number of Protest is 1.6 times. The most recently Protest patent is 特開2023-044274 "皮膚外用剤" (Protest day 2024-11-21) , next is 特表2022-500417 "咬筋肥大症の治療方法" (Protest day 2024-11-13) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-044274 | 皮膚外用剤 | 2024-11-21 |
| 2 | 特表2022-500417 | 咬筋肥大症の治療方法 | 2024-11-13 |
| 3 | 特開2022-183421 | プロスタグランジンＥ２産生抑制皮膚外用剤 | 2024-11-07 |
| 4 | 特表2024-513726 | 絹でコーティングされた合成繊維 | 2024-10-31 |
| 5 | 特開2022-070845 | 浸透促進方法 | 2024-10-30 |
| 6 | 特表2024-504235 | グリシネート界面活性剤と、ポリオールと、アルキルグルコシドを含む非イオン性界面活性剤とを含むパーソナルケア組成物 | 2024-10-23 |
| 7 | 特表2024-524951 | 生分解性高吸水性樹脂およびその製造方法 | 2024-10-21 |
| 8 | 特開2021-053398 | 皮膚用貼付材 | 2024-10-18 |
| 9 | 特開2020-117500 | 皮膚外用組成物 | 2024-10-18 |
| 10 | 特開2022-100629 | 梅テイスト飲料 | 2024-10-18 |
| 11 | 特開2024-075519 | 抗ウイルス組成物 | 2024-10-16 |
| 12 | 特開2024-075507 | 抗ウイルスコーティング剤 | 2024-10-16 |
| 13 | 特開2021-134208 | 耐水性油中水サンケア配合物のための生分解性ポリエステル | 2024-10-10 |
| 14 | 特開2021-134351 | 耐水性水中油サンケア配合物のための生分解性ポリエステル | 2024-10-10 |
| 15 | 特開2021-134209 | 耐水性無水サンケア配合物のための生分解性ポリエステル | 2024-10-10 |
| 16 | 特開2021-123532 | 皮膚外用組成物 | 2024-10-04 |
| 17 | 特表2023-512944 | 固体バイオマス燃料を生成するための方法 | 2024-10-01 |
| 18 | 特表2023-514396 | 抗菌組成物 | 2024-09-27 |
| 19 | 特開2021-169438 | 水中油型乳化組成物 | 2024-09-26 |
| 20 | 特開2020-200317 | 大気有害物質の付着抑制方法 | 2024-09-19 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 587 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特開2020-193227 "外用組成物" (13 times) , and the next most protest patent is 特開2021-123532 "皮膚外用組成物" (11 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2020-193227 | 外用組成物 | 13 times |
| 2 | 特開2021-123532 | 皮膚外用組成物 | 11 times |
| 3 | 特開2021-161042 | 組成物 | 7 times |
| 4 | 特開2020-117500 | 皮膚外用組成物 | 7 times |
| 5 | 特許6764792 | ケラチン処理調合物及び方法 | 6 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 610 patents Inspection from third parties. The average number of Inspection is 1.7 times. The most recently Inspection patent is 特表2021-525595 "薄型多剤注入システムおよび方法" (Inspection day 2024-11-22) , next is 特表2022-527736 "ムース製品、方法及び装置" (Inspection day 2024-11-22) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2021-525595 | 薄型多剤注入システムおよび方法 | 2024-11-22 |
| 2 | 特表2022-527736 | ムース製品、方法及び装置 | 2024-11-22 |
| 3 | 特表2022-517456 | 臓器健康および疾患をモニタリングするための方法およびシステム | 2024-11-21 |
| 4 | 特表2022-514116 | 新規な癌抗原及び方法 | 2024-11-21 |
| 5 | 特表2022-500417 | 咬筋肥大症の治療方法 | 2024-11-18 |
| 6 | 特開2022-091866 | 針刺入装置及び薬物アプリケーター | 2024-11-15 |
| 7 | 特開2021-123532 | 皮膚外用組成物 | 2024-11-14 |
| 8 | 特開2022-100629 | 梅テイスト飲料 | 2024-11-13 |
| 9 | 特許7513305 | ３次元培養された幹細胞から細胞外小胞体を製造する方法 | 2024-11-12 |
| 10 | 特開2021-063061 | シワ改善用皮膚外用剤 | 2024-11-12 |
| 11 | 特開2022-183421 | プロスタグランジンＥ２産生抑制皮膚外用剤 | 2024-11-11 |
| 12 | 特表2024-532430 | 血管の経皮的閉鎖の検出および圧力除去 | 2024-11-08 |
| 13 | 特開2023-060159 | 外用組成物 | 2024-11-08 |
| 14 | 特表2022-554318 | 神経血管インターベンションシステム及び方法 | 2024-11-08 |
| 15 | 特表2022-530926 | 耐薬品性及び耐湿性を有する可撓性基材 | 2024-11-07 |
| 16 | 特表2024-512769 | 抗原特異的Ｔ細胞を生成し、疾患を治療するための材料及び方法 | 2024-11-06 |
| 17 | 特開2020-193227 | 外用組成物 | 2024-10-25 |
| 18 | 特表2022-537570 | がんを処置する方法 | 2024-10-23 |
| 19 | 特開2024-075519 | 抗ウイルス組成物 | 2024-10-22 |
| 20 | 特開2024-075507 | 抗ウイルスコーティング剤 | 2024-10-22 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 1,214 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.5. The most inspection patent is 特開2017-149726 "Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) , and the next most inspection patent is 特許7376250 "皮膚外用組成物" (30 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-149726 | Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
| 2 | 特許7376250 | 皮膚外用組成物 | 30 times |
| 3 | 特許6407064 | 両親媒性ポリマーを含む水中油型エマルジョン | 25 times |
| 4 | 特開2021-123532 | 皮膚外用組成物 | 24 times |
| 5 | 特許7058943 | 水中油型乳化組成物 | 19 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 6,546 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.4. The most cited patent is 特許6594413 "携帯デバイスを介する非侵襲的神経刺激" (67 times) , and the next most cited patent is 特開2019-019077 "皮膚外用組成物" (62 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6594413 | 携帯デバイスを介する非侵襲的神経刺激 | 67 times |
| 2 | 特開2019-019077 | 皮膚外用組成物 | 62 times |
| 3 | 特許6280287 | タバコ植物または非タバコ植物を用いた電子タバコカートリッジおよびその支持部材 | 52 times |
| 4 | 特開2016-128031 | 挿入器を検体モニタ装置に係合するシステムおよび挿入器を検体モニタ装置に係合する方法 | 46 times |
| 5 | 特許7210586 | シリコーンエラストマーおよび皮膚軟化剤を含む化粧品組成物 | 39 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.